<DOC>
	<DOC>NCT01147055</DOC>
	<brief_summary>The purpose of this study is to estimate the effect of multiple doses of Rifampin on the single dose pharmacokinetics of Crizotinib in healthy volunteers.</brief_summary>
	<brief_title>Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Crizotinib</mesh_term>
	<criteria>Healthy male and/or female of nonchild bearing potential subjects between the ages of 18 and 55 years, inclusive (Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and pulse rate measurement, 12lead ECG and clinical laboratory tests). Body Mass Index (BMI) of 17.5 to 30.5 kg/m^2; and a total body weight &gt;50 kg (110 lbs). Subjects with evidence of disease, conditions affecting drug absorption, treatment with other investigational drug within 30 days, history of regular alcohol consumption, and use of prescription , nonprescription drugs and dietary supplement within 7 days, and blood donation of 500 mL within 56 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>crizotinib</keyword>
	<keyword>healthy volunteers</keyword>
	<keyword>rifampin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>single dose</keyword>
</DOC>